Delisting riskPopularity #4,965
Sonoma Pharmaceuticals (SNOA)
Develops and manufactures shelf-stable hypochlorous-acid products for wound, skin, eye, foot, animal, and surface care.
$1.27
vs last close+0.02 (+1.60%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 6.58% | 110.8K shares | |
|---|---|---|---|
| 14 holders · as of Jun 30, 2026 | |||
| Other | 93.42% | 1.57M shares | |
| remainder | |||
1.68M company shares as of Sep 19, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (4.79M in the company's Sep 22, 2026 report, 1.68M elsewhere); stakes use the report.
13F, as of Jun 30, 2026
14 holders · 110.8K shares · 4 new positions · 6 increased · 1 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Renaissance Technologies LLC | 40.5K | 2.40% | +40.5Knew | Aug 13, 2026 |
| Geode Capital Management, LLC | 26.8K | 1.59% | +6.8K | Aug 12, 2026 |
| Vanguard Capital Management LLC | 18.8K | 1.12% | 0 | Aug 13, 2026 |
| Mckinley Carter Wealth Services, Inc. | 11.2K | 0.66% | 0 | Jul 28, 2026 |
| UBS Group AG | 7.8K | 0.46% | +7.8K | Aug 13, 2026 |
| Global Retirement Partners, LLC | 2.5K | 0.15% | +2.5Knew | Aug 6, 2026 |
| Morgan Stanley | 2.0K | 0.12% | −4 | Aug 13, 2026 |
| Advisor Group Holdings, Inc. | 500 | 0.03% | 0 | Aug 14, 2026 |
13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.
